These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9067919)

  • 21. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular filtration rate measurement in cirrhotic patients with renal failure.
    Roy L; Legault L; Pomier-Layrargues G
    Clin Nephrol; 1998 Dec; 50(6):342-6. PubMed ID: 9877106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of renal failure on the growth hormone-insulin-like growth factor axis.
    Powell DR
    J Pediatr; 1997 Jul; 131(1 Pt 2):S13-6. PubMed ID: 9255220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.
    Lepenies J; Wu Z; Stewart PM; Strasburger CJ; Quinkler M
    Growth Horm IGF Res; 2010 Apr; 20(2):93-100. PubMed ID: 19932629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of human recombinant insulin-like growth factor-I in critically ill patients.
    Yarwood GD; Ross RJ; Medbak S; Coakley J; Hinds CJ
    Crit Care Med; 1997 Aug; 25(8):1352-61. PubMed ID: 9267949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.
    Lakatos P; Foldes J; Nagy Z; Takacs I; Speer G; Horvath C; Mohan S; Baylink DJ; Stern PH
    Thyroid; 2000 May; 10(5):417-23. PubMed ID: 10884189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
    Clemmons DR; Sleevi M; Allan G; Sommer A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of graded renal ablation on kidney and serum insulin-like growth factor-I (IGF-I) and IGF binding proteins in rats: relation to compensatory renal growth.
    Grønboek H; Nielsen B; Flyvbjerg A; Orskov H
    Metabolism; 1997 Jan; 46(1):29-35. PubMed ID: 9005965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone/insulin-like growth factor system in children with chronic renal failure.
    Tönshoff B; Kiepe D; Ciarmatori S
    Pediatr Nephrol; 2005 Mar; 20(3):279-89. PubMed ID: 15692833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-I/IGFBP-1 as an index for discrimination between responder and nonresponder to recombinant human growth hormone in malnourished uremic patients on hemodialysis.
    Shinobe M; Sanaka T; Nihei H; Sugino N
    Nephron; 1997; 77(1):29-36. PubMed ID: 9380235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.
    Jarkovská Z; Hodková M; Sazamová M; Rosická M; Dusilová-Sulková S; Marek J; Justová V; Lacinová Z; Haluzík M; Haas T; Krsek M
    Growth Horm IGF Res; 2005 Dec; 15(6):369-76. PubMed ID: 16198134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome.
    Lee DY; Park SK; Kim JS
    J Clin Endocrinol Metab; 1996 May; 81(5):1856-60. PubMed ID: 8626847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
    Holt RI; Baker AJ; Jones JS; Miell JP
    Pediatr Transplant; 1998 Feb; 2(1):76-84. PubMed ID: 10084765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
    Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
    Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.